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Abstract
Background: The health positive effects of diets high in fruits and vegetables are generally not replicated in
supplementation trials with isolated antioxidants and vitamins, and as a consequence the emphasis of chronic
disease prevention has shifted to whole foods and whole food products.
Methods: We carried out a human intervention trial with the golden kiwifruit, Actinidia chinensis, measuring
markers of antioxidant status, DNA stability, plasma lipids, and platelet aggregation. Our hypothesis was that
supplementation of a normal diet with kiwifruits would have an effect on biomarkers of oxidative status. Healthy
volunteers supplemented a normal diet with either one or two golden kiwifruits per day in a cross-over study
lasting 2 × 4 weeks. Plasma levels of vitamin C, and carotenoids, and the ferric reducing activity of plasma (FRAP)
were measured. Malondialdehyde was assessed as a biomarker of lipid oxidation. Effects on DNA damage in
circulating lymphocytes were estimated using the comet assay with enzyme modification to measure specific
lesions; another modification allowed estimation of DNA repair.
Results: Plasma vitamin C increased after supplementation as did resistance towards H2O2-induced DNA damage.
Purine oxidation in lymphocyte DNA decreased significantly after one kiwifruit per day, pyrimidine oxidation
decreased after two fruits per day. Neither DNA base excision nor nucleotide excision repair was influenced by
kiwifruit consumption. Malondialdehyde was not affected, but plasma triglycerides decreased. Whole blood platelet
aggregation was decreased by kiwifruit supplementation.
Conclusion: Golden kiwifruit consumption strengthens resistance towards endogenous oxidative damage.
Introduction
Diets rich in fruits and vegetables offer protection
against the development of cardiovascular diseases
(CVD), diabetes and cancer [1-3]. A common factor in
the aetiology of these diseases seems to be damage to
biomolecules caused by reactive oxygen species. Power-
ful endogenous antioxidant defences are thought to be
augmented by dietary antioxidants, and so much of the
protective effect of fruits and vegetables has been
attributed to their high content of antioxidants [4,5].
However, attempts to boost human resistance to cardio-
vascular disease and cancer through supplementation
trials with isolated antioxidants and vitamins have
proved disappointing [6-8], and there is no reason to
believe that negative effects of unhealthy diets and life-
style can be remedied through the use of antioxidant
supplements. Hence, the emphasis of chronic disease
prevention policy has shifted to whole foods and whole
food products. In addition to recognised antioxidants
such as vitamins C and E, carotenoids and flavonoids,
fruits and vegetables contain innumerable other phyto-
chemicals, with known or (mostly) unknown effects on
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human metabolism. Antioxidant activity is clearly not
the whole story.
Kiwifruit is particularly rich in vitamin C (ascorbic
acid), but also contains a wide range of other phyto-
chemicals. The common green kiwifruit, Actinidia deli-
ciosa, has been used as a ‘model’ fruit in several trials to
examine effects on biomarkers relevant to both cancer
and CVD. Typically green kiwifruit contains approxi-
mately 85 mg vitamin C per 100 mg fresh weight [9]. A
kiwifruit extract has powerful antioxidant activity in
vitro [10], and in humans, regular consumption of this
fruit inhibits platelet aggregation [11], decreases endo-
genous oxidation of lymphocyte DNA, protects lympho-
cyte DNA from oxidation in vitro, and enhances the
capacity of lymphocytes to repair DNA oxidation
damage [10,12-15]. The more recently available ‘golden’
kiwifruit Actinidia chinensis var. Hort 16A, differs signif-
icantly in phytochemical make-up (with 20% higher vita-
min C content [9]), demonstrating higher FRAP values
[16] than the green kiwifruit. Based on these properties
the golden kiwifruit would be expected to show stronger
protection against effects of oxidative damage in-vivo.
To test this hypothesis, we conducted a human dietary
intervention trial with golden kiwifruit, examining
potential effects on platelet function, plasma antioxidant
status, DNA oxidation, and base excision repair (BER),
as well as nucleotide excision repair (NER) activity.
Plasma malondialdehyde (MDA) was measured by
HPLC. As a product of lipid peroxidation, it acts as a
marker for overall oxidative stress.
Our results indicate that golden kiwifruit strengthens
our resistance towards endogenous oxidative damage,
but our results do not support the view that the golden
kiwifruit provides noticeably stronger protection against
oxidative damage than the green variety.
Experimental Methods
Study design and participants
Twenty-four men and women (20-57 years, BMI 20-30 kg/
m²) were recruited from the university and neighbouring
companies through poster advertising and email cam-
paigns. After a screening interview, subjects eating modest
amounts of fruits and vegetables were selected. Exclusion
criteria were: use of contraceptive pills, medicines or sup-
plements; diets aimed at weight correction; diagnosed dia-
betes, cancer or cardiovascular disease; habitual
consumption of >30 units of alcohol/week (15 glasses of
wine); habitual undertaking of >6h vigorous exercise/week
(assessed by exercise questionnaires completed at screen-
ing session); abnormal menstrual cycle/hormone replace-
ment therapy; or a high intake of fruits and vegetables (>
450 grams per day). The study was approved by the regio-
nal committee of ethics in medical science. Written con-
sent was obtained from all participants.
Subjects received two different ‘doses’ of kiwifruit in
two 4-week supplementation periods separated by a 4-
week washout period. The cross-over design of the
study minimises so-called seasonal effects. Subjects were
randomized into two groups taking the kiwifruit doses
in different order; either one kiwifruit per day in the
first period, two in the second, or two per day in the
first period, one in the second. Subjects were not given
specific times at which to consume the fruit, but were
asked to add the fruit to their normal diet. They were
specifically instructed to avoid increasing their habitual
low to moderate intake of fruits and vegetables.
Blood sampling
Four venous blood samples were taken from overnight-
fasted subjects: 1) pre-intervention, first period; 2) post-
intervention, first period; 3) pre-intervention, second
period; 4) post-intervention, second period. A pre-study
run-in sample was taken to practice sampling routines.
A post-study sample was taken to check for return to
baseline levels 4 weeks after the end of supplementation.
Blood was collected in Cell Preparation Tubes (Beck-
ton Dickinson) and centrifuged (700 × g, 10 min at 4°C)
to separate plasma, red cells and mononuclear cells.
Plasma aliquots were snap-frozen in liquid nitrogen and
stored at -80°C; those intended for vitamin C analysis
were acidified with an equal volume of 10% meta-phos-
phoric acid (MPA). The MPA solution was freshly pre-
pared (within 14 days) and stored at 4°C. Mononuclear
cells were analysed for DNA damage on the day of iso-
lation. Mononuclear cells suspended in 45 mM HEPES,
0.4 M KCl, 1 mM EDTA, 0.1 mM dithiothreitol, 10%
glycerol, pH7.8 at 5 × 107 cells per ml were snap-frozen
in liquid nitrogen and stored at -80°C for use in the in
vitro BER and NER assays.
Measurement of plasma vitamin C
The frozen, acidified samples were thawed, and centri-
fuged (3500 × g) at +4°C for 10 min. Following the sen-
trifugation of the acidified heparin plasma, 100 μL of
the clear supernatant was diluted with 400 μL of the
mobile phase (2% acetonitrile in 2.5 mM NaH2PO4, 2.5
mM dodecyltrimethyl ammonium chloride and 1.25
mM Na2EDTA in Milli-Q water) for direct determina-
tion of ascorbic acid (AA). For the determination of
total ascorbic acid (TAA), 100 uL of the clear superna-
tant was subjected to reduction for 7 min with the addi-
tion of 50 μL 2.3 mmol/L TCEP in 800 mmol/L
trizmabuffer (pH 9.0). Subsequently, 350 μL of the
mobile phase was added. For separation of ascorbic acid
from interfering plasma constituents, a Chromolith Per-
formance RP18-e, 4.6 mm × 100 mm column was used,
with a Chromolith Performance RP18-e, 4.6 mm × 10
mm guard column. The injection volume used was 5 μL
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and the flow rate was 6.0 mL/min. A variable wave-
length UV detector was used at 264 nm. A detailed pro-
tocol has been published [17].
Measurement of plasma carotenoids
The carotenoids lutein, zeaxanthin, b-kryptoxanthin, a-
carotene, b-carotene and lycopene were determined in
plasma by HPLC. Proteins were precipitated and
removed by the addition of a 450 μL isopropanol to 100
μL plasma, followed by centrifugation at 3.000 g at 4°C
for 15 min. The internal standard astaxanthin was
added with the isopropanol. Twenty five μL of the clear
supernatant were used for analysis. The mobile phases
consisted of A: 20% water and 24% acetone in ethanol
and B: acetone. The gradient conditions were as follows:
From 2 to 100% mobile phase B within 20 min, followed
by 100% mobile phase B for 15 min. Detection was per-
formed at 453 nm using a variable wavelength detector.
Plasma calibrators quantified against the NIST 968c
SRM were used as standards.
FRAP assay
Ferric Reducing Activity of Plasma (FRAP) was deter-
mined as described [18]. The modified assay measures
FRAP after removal of uric acid and proteins from the
plasma and more accurately indicates the contribution
of dietary antioxidants. Briefly, 30 μl uricase (0.1 unit/10
μl in Tris buffer, pH 8.5) was added to 60 μl plasma at
room temperature. The samples were incubated for 6
min. 120 μl absolute ethanol was added and the samples
were vortex-mixed. After incubation for 5 min at 4°C to
allow complete protein precipitation, the samples were
centrifuged at 13,000 × g for 5 min. The supernatant
was used for FRAP analysis as described [18].
Measurement of malondialdehyde in plasma
Plasma samples were diluted ten-fold in a final reaction
mix containing 0.8% SDS, 10% acetic acid, and 0.17%
thiobarbituric acid, incubated for 1 h at 100°C, centri-
fuged, and then injected (50 μL) onto a Chromolith Per-
formance RP 18e 10 cm (internal diameter: 3 cm)
column (Merck) connected to a Brownlee pre-column
(RP-18, 5u, OD-GU, 30 × 4,6 mm); the mobile phase
was a 6:4 mixture of 50 mM sodium phosphate buffer,
pH 6.8, and methanol. Detection was by fluorescence
(excitation 532 nm, emission 553 nm) with a Hewlett
Packard 1046A programmable detector.
Plasma lipids and other plasma components
The blood samples were sent to a certified medical
laboratory (Fürst Medical Laboratory, Oslo, Norway) for
lipid and glucose analyses. Serum blood samples were
analyzed for total-, HDL- and LDL-cholesterol, triacyl-
glycerols (TAG), and glucose using automated
photometric techniques (Modular P Roche; Roche Diag-
nostics). Plasma LDL-cholesterol was calculated using
the Friedwald formula [19]. Plasma fibrinopeptide A
(FPA) concentration was measured by competitive
ELISA and plasma C-reactive protein (CRP) concentra-
tion using a semi-quantitative latex agglutination assay,
as described [20,21].
DNA damage measured in mononuclear cells
The comet assay (single cell gel electrophoresis) [22]
was used to measure DNA strand breaks. Mononuclear
cells were embedded in low melting point agarose (1%,
75 μL) on microscope slides. Gels were allowed to set at
4°C. Cells were lysed for 1h in 2.5 M NaCl, 0.1 M
Na2EDTA, 10 mM Tris-HCl, pH 10, 1% Triton X-100 at
4°C to remove membranes, cytoplasm and most nuclear
proteins, leaving DNA as nucleoids. To measure strand
breaks, the slides were then immersed in elctrophoresis
solution (0.3 M NaOH, 1 mM Na2EDTA) for 40 min at
4°C and then electrophoresed at 0.8 V/cm for 30 min at
an ambient temperature of 4°C. DNA loops containing
breaks extend under electrophoresis to form ‘comet
tails’, and the relative intensity of DNA in the tail indi-
cates the DNA break frequency. After neutralisation,
gels were stained with 4`,6-diamidine-2`-phenylindole
dihydrocloride (DAPI) and viewed by fluorescence
microscopy. Tail intensity was assessed by visual scoring;
100 comets selected at random were graded according
to degree of damage into five classes (0-4) to give an
overall score for each gel of between 0 and 400 arbitrary
units [22]).
In addition to frank DNA strand breaks, oxidised
bases were measured by incubating, after lysis, with
endonuclease III (to detect oxidised pyrimidines) or for-
mamidopyrimidine DNA glycosylase (FPG, recognising
8-oxoGua and other oxidised purines) in 40 mM
HEPES, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/ml bovine
serum albumin (pH adjusted to 8.0) for 30 min at 37°C.
Net enzyme-sensitive sites were calculated by subtract-
ing the comet score after incubation with buffer alone
from the score with enzyme. Due to a comet assay cali-
bration problem in the first intervention period with
respect to assessment of endonuclease III sensitive sites,
we choose to base all our endonuclease III calculations
on samples from the second intervention period. This
reduced the effective sample size of endonuclease III
sensitive sites from 24 to 12.
In vitro assay for DNA repair capacity
In this assay, a mononuclear cell extract is incubated
with DNA substrate containing specific damage; either
8-oxoGua (to measure BER), or cyclobutane pyrimidine
dimers (to measure NER) [22]. HeLa cells were used to
prepare substrate for the BER assay by incubating them
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with 1 μM Ro 19-8022 (gift from F. Hoffmann-La
Roche) and irradiating on ice with visible light (5 min at
30 cm from a 500 W tungsten halogen source). As sub-
strate for the NER assay, HeLa cells were irradiated on
ice with 1 Jm2 ultraviolet light (UVC). Substrate cells
were embedded in agarose and lysed as in the standard
comet assay (above). To a thawed aliquot of snap-frozen
lymphocytes, 1% Triton X-100 was added to a final con-
centration of 0.2%, the lysate was centrifuged (15,000 ×
g, 5 min, 4°C) and the supernatant mixed with 4
volumes of the endonuclease III/FPG incubation buffer
(see above) - with addition of 1.6 mM MgCl2 in the
case of the NER assay [23]. Forty five μL of extract was
added to the agarose gel containing substrate nucleoids,
incubated for 10 min (BER) or 30 min (NER) and then
processed as in the standard comet assay. The produc-
tion of DNA breaks during the incubation indicates the
ability of the extract to carry out the the initial stage of
NER. One repair extract was destroyed accidentally in
group 2, reducing the effective size of DNA repair sam-
ples to 23.
Gene expression analysis
The blood was collected in Tempus™ blood RNA tubes
(4342792, Applied Biosystems). Tempus™ spin RNA
isolation kit (4380204, Applied Biosystems) was used
with the optional DNase treatment wash buffer
(4305545, Applied Biosystems). The extracted RNA was
quantified spectophotometrically (NanoDrop) and stored
at -80°C. The RNA integrity was assessed on Experion
(Bio-Rad) and all samples included in the analysis had
RQI values higher than 8. The RNA concentrations
were normalized before reverse transcription with the
Transcriptor First Strand Synthesis Kit (04896866001,
Roche Diagnostics). 5 ng cDNA was added to each PCR
reaction and the qPCR was performed using assays from
DNA Damage Response Gene Panel (G101, TATAA
Biocenter AB) with primer concentrations of 300 nM.
The PCR program consisted of 95°C for 3 min, 40 cycles
of 95°C for 10 sec, 60°C for 10 sec and 72°C for 10 sec
followed by a melt curve with a predenaturation step at
95°C and a melting range of 65-95°C. The PCR was per-
formed on LightCycler® 480 (Roche Diagnostics) using
PerfeCTa® SYBR® green SuperMix, Low Rox™ (95056-
02K, Quanta Biosciences) and VisiBlue™ qPCR mix col-
orant (K101, TATAA Biocenter AB). Assays for 12 can-
didate reference genes from the Human endogenous
control gene panel (A101, TATAA Biocenter AB) were
analyzed for all samples. The two most stable (beta-
actin and beta-glucuronidase) were selected using
GenEx software (MultiD Analyses AB) and used for nor-
malization. Matched samples of RNA from blood col-
lected before and after supplementation were analysed
by quantitative RT-PCR using probes to genes for DNA
repair and related processes. The number of paired sam-
ples available for gene expression studies was limited to
seven.
Whole blood platelet aggregation
A Chronolog whole blood aggregometer was used to
measure the electrical resistance (impedance) to the pas-
sage of small electric current across two platinum elec-
trodes immersed in the sample of blood. Platelet
aggregation increases impedance. For whole blood
aggregation, blood (5 ml) mixed with sodium citrate
(final concentration 13 mM) was kept at room tempera-
ture for 15 min. Typically, 0.5 mL of blood and 0.5 mL
of PBS were placed in a plastic cuvette at 37°C. ADP
and collagen at various concentrations were used to
initiate the aggregation response [16,24,25]. Due to a
technical problem with the aggrometer electrode results
from whole blood aggregation measurements are based
exclusively on the second intervention period.
Statistical analysis
Results are presented as the mean ± SEM. Student’s t
tests were used to test for differences before and after
treatment. Results from intervention groups were com-
bined so that data for all subjects receiving one kiwifruit
per day, whether in the first or second period, were ana-
lysed together, and similarly all data for two per day.
Values were considered to be significantly different
when p < 0.05. Simple regression analysis was per-
formed to evaluate correlation between plasma vitamin
C and strand breaks.
Results
Both reduced ascorbic acid and total (reduced plus
dehydro-) ascorbic acid increased after supplementation
with kiwifruit (Table 1), reduced ascorbic acid being
borderline significant (p = 0.054) and total ascorbic acid
approaching statistical significance (p = 0.068) at 2 kiwi-
fruits per day. No differences were seen between pre-
and post-intervention plasma levels of the carotenoids
or FRAP values (Table 1). There were no changes in
plasma MDA as a result of kiwifruit supplementation
(Table 1).
Table 2 shows plasma concentrations of total choles-
terol, HDL, LDL, triglycerides and glucose. Mean glucose,
cholesterol, LDL, and HDL cholesterol values were
unchanged over the 4-week intervention periods, whereas
triglyceride concentrations were significantly lower (by
approximately 13%) after supplementation with 1 or 2
kiwifruits per day. Plasma concentrations of FPA over 6
ng/ml were assumed to be the result of unsatisfactory
venepuncture and excluded from data analysis; this
applied to 4 out of 180 samples. CRP has been shown to
induce cytokine imbalance which affects many aspects of
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platelet function. Base levels of hsCRP (CRP measured
with a high sensitivity assay) were 2.34 ± 0.05 mg/L, and
were not affected by consumption of kiwifruit.
Kiwifruit supplementation, both one and two per day,
significantly decreased H2O2-induced DNA damage
(Table 3). Following 4 weeks of golden kiwifruit inter-
vention, a decrease in FPG-sensitive sites in lymphocyte
DNA was observed (Table 3), though the decrease was
statistically significant only after one kiwifruit per day.
Decreases in endonuclease III-sensitive sites were signif-
icant after 2 kiwifruits per day but not after one per day
(Table 3). In the in vitro DNA repair assays, extract pre-
pared from lymphocytes is incubated with specifically
damaged DNA containing 8-oxoGua for assessing BER,
and cyclobutane pyrimidine dimers for NER. No change
in either BER or NER activity was observed following
supplementation (Table 3). At two fruits per day there
was a borderline significant inverse correlation between
plasma levels of reduced vitamin C and lymphocyte
strandbreaks (Pearson’s r = -0.55, p = 0.066).
No differences in the expression of any of the genes
studied were observed before and after kiwifruit con-
sumption (Table 4).
Table 5 shows the whole blood platelet aggregation
response to different concentrations of ADP and col-
lagen before and after daily consumption of kiwifruit.
Whole blood platelet aggregation induced by ADP was
reduced at both concentrations after consuming 1 kiwi-
fruit per day; however significance was attained only in
the case of 5.0 μM ADP. We observed after 1 kiwifruit
per day a significant reduction in whole blood platelet
aggregation in response to collagen at 2 μg/ml.
Table 1 Plasma antioxidants, FRAP and MDA measured before and after kiwifruit intervention (n = 24)
Fruits Before After Diff Change p
Mean SEM Mean SEM Mean SEM (%)
(μmol/L) (μmol/L) (μmol/L)
Total ascorbic acid 1 57.11 15.6 59.58 10.9 2.5 19.0 4 0.53
2 52.83 13.3 60.27 14.3 7.4 19.5 14 0.07
Ascorbic acid, reduced 1 52.79 14.7 55.66 11.2 2.9 18.5 5 0.45
2 47.97 13 55.43 13.1 7.5 18.5 16 0.05
Lutein, μmol/L 1 0.22 0.1 0.22 0.1 0.0 0.1 0 0.95
2 0.22 0.1 0.23 0.1 0.0 0.1 5 0.70
b-Cryptoxanthin, μmol/L 1 0.32 0.3 0.31 0.3 0.0 0.4 -3 0.92
2 0.31 0.3 0.31 0.3 0.0 0.4 0 0.99
a-Carotene, μmol/L 1 0.14 0.1 0.14 0.1 0.0 0.1 0 0.91
2 0.14 0.1 0.14 0.1 0.0 0.1 0 0.98
b-Carotene, μmol/L 1 0.55 0.3 0.56 0.4 0.0 0.5 2 0.89
2 0.55 0.3 0.56 0.3 0.0 0.4 2 0.97
Zeaxanthin, μmol/L 1 0.05 0 0.04 0 0.0 0.0 -20 0.91
2 0.04 0 0.04 0 0.0 0.0 0 0.87
Lycopene, μmol/L 1 0.57 0.1 0.57 0.1 0.0 0.1 0 0.99
2 0.57 0.2 0.56 0.1 0.0 0.2 -2 0.97
FRAP1, μmol/L 1 1203.17 208 1201.13 228.5 -2.0 309.0 0 0.97
2 1189.38 243.9 1260.46 164.4 71.1 294.1 6 0.24
MDA2, μmol/L 1 0.88 0.4 0.88 0.3 0.0 0.5 0 0.97
2 0.89 0.5 0.88 0.5 0.0 0.7 -1 0.53
SEM: standard error of the mean. 1Ferric reducing activity of plasma. 2Malondialdehyde.
Table 2 Effects of kiwifruit consumption on fasting
plasma levels of lipids and glucose (n = 24)
Before After Diff Change p
Mean SEM Mean SEM Mean SEM (%)
(mM) (mM) (mM)
One kwifruit per day
Glucose 4.79 0.1 4.69 0.1 -0.10 0.1 -2.1 0.41
HDL 1.53 0.1 1.52 0.1 -0.01 0.1 -6.5 0.71
LDL 2.32 0.1 2.20 0.1 -0.12 0.1 -3.4 0.68
Total
cholesterol
4.05 0.1 3.83 0.1 -0.22 0.2 -4.4 0.26
Triglycerides 0.88 0.1 0.76 0.1 -0.12 0.1 -13.3 0.05
Two kwifruits per day
Glucose 4.68 0.1 4.80 0.1 0.12 0.1 2.6 0.20
HDL 1.50 0.1 1.43 0.1 -0.07 0.1 -7.1 0.26
LDL 2.39 0.1 2.51 0.1 0.12 0.1 3.3 0.57
Total
cholesterols
4.05 0.1 4.10 0.1 0.05 0.2 4.7 0.51
Triglycerides 0.86 0.1 0.76 0.0 -0.10 0.1 -7.4 0.05
SEM: standard error of the mean
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Consuming 2 kiwifruits per day had no significant effect
on whole blood platelet aggregation.
In vitro whole blood platelet aggregation was mea-
sured in the presence of undiluted green or golden kiwi-
fruit extract. At similar wet weight the green fruit
extract was almost twice as effective as golden kiwifruit
extract at inhibiting ADP-induced whole blood platelet
aggregation. In contrast, golden kiwifruit extract was sig-
nificantly more effective than green kiwifruit extract at
inhibiting collagen-induced platelet aggregation (data
not shown).
Discussion
Here we report increases in plasma vitamin C and
increases in total antioxidant capacity (as indicated by
H2O2-induced DNA damage) as well as a trend towards
decrease in oxidised pyrimidines and oxidised purines.
Previously, we reported increases in mean plasma vita-
min C concentrations of up to 26% after suplementation
with 3 green kiwifruits per day for 3 weeks [26]. There
were no restrictions in either study as to when during
the day the fruit should be eaten, and in practice the
last fruit was consumed 10 h or more prior to blood
sampling. Peak plasma vitamin C concentrations are
reached a few hours after supplementation and then
decline [27], and so the 14-16% increase in vitamin C
seen here is all the more impressive. Measured a short
time after kiwifruit consumption, the concentration
would presumably have been much higher. This increase
in plasma concentration of reduced and total ascorbic
acid indicates that (golden) kiwifruit may be an effective
booster of antioxidant status, especially since vitamin C
activity is likely to be enhanced by acting in concert
with other phytochemicals from fruit.
Table 3 Endogenous DNA damage and DNA repair activity in lymphocytes, before and after kiwifruit intervention;
Arbitrary units (n = 24)
Fruits Before After Diff Differ (%) p
Mean SEM Mean SEM Mean SEM
FPG-sensitive sites 1 196.38 73.7 130.33 85.3 -66.05 112.7 -34 0.01
2 188.58 61.5 148.26 106.7 -40.32 123.2 -21 0.12
Endonuclease III-sensitive sites1 1 139.42 71.1 104.00 59.8 -35.42 92.9 -25 0.20
2 138.17 41.2 92.25 62.1 -45.92 74.5 -33 0.04
Resistance towards H2O2 oxidation 1 283.08 43.9 189.25 117.2 -93.83 125.2 -33 0.00
2 278.00 51.6 191.52 124.5 -86.48 134.8 -31 0.00
Base exision repair (BER) 1 48.43 16.3 46.61 14.5 -1.82 21.8 -4 0.69
2 52.54 13.8 49.11 15.1 -3.43 20.5 -7 0.43
Nucleotide excision repair (NER)2 1 39.38 21.3 38.13 23.9 -1.25 32.0 -3 0.85
2 37.71 18.8 35.50 23.3 -2.21 29.9 -6 0.72
SEM: standard error of the mean. 1Based on samples exclusively from the second intervention period (n = 12). 2n = 23.
Table 4 Expression of essential DNA repair genes in seven randomly selected subjects during kiwifruit consumption
and after wash-out
Before After Diff Change p
Mean SEM Mean SEM Mean SEM (%)
Cyclin-dependent kinase inhibitor 1A (p21) 5.32 0.1 5.28 0.2 -0.04 0.2 -0.8 0.80
Replication protein A1 (RPA1) 6.15 0.1 6.31 0.1 0.16 0.2 2.6 0.28
Xeroderma pigmentosum, complementation group A (XPA) 5.56 0.2 5.38 0.2 -0.18 0.2 -3.2 0.30
Excision reapir cross-complementing protein 1 (ERCC1) 3.55 0.1 3.48 0.2 -0.07 0.2 -2.0 0.67
Excision reapir cross-complementing protein 2 (ERCC2) 4.87 0.1 4.79 0.3 -0.08 0.3 -1.6 0.77
8-oxoguanine DNA glycosylas (OGG1) 4.83 0.1 4.83 0.1 0 0.2 0.0 1.00
Proliferating cell nuclear antigen (PCNA) 5.06 0.2 5.01 0.2 -0.05 0.2 -1.0 0.75
X-ray repair cross-complementing protein (XRCC1) 4.07 0.2 3.92 0.1 -0.15 0.2 -3.7 0.41
NAD(P)H dehydrogenase, quinone 1 (NQO1) 7.40 0.1 7.32 0.2 -0.08 0.2 -1.1 0.54
Nuclease (multifunctional DNA repair enzyme) 1 (APEX1) 3.08 0.1 3.00 0.2 -0.08 0.2 -2.6 0.52
Homolog recombination protein (RecA homolog, E. coli)(RAD51) 11.68 0.3 11.58 0.2 -0.1 0.3 -0.9 0.81
Xeroderma pigmentosum, complementation group C (XPC) 4.49 0.1 4.59 0.2 0.1 0.2 2.2 0.58
SEM: standard error of the mean.
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After both one and two fruits per day resistance
towards H2O2-oxidation increased by ~30%. The
reduced level of strandbreaks may in part be caused by
the increased intake of vitamin C. At two fruits per day
there was a borderline significant inverse correlation
between plasma levels of reduced vitamin C and lym-
phocyte strandbreaks, but this association was not pre-
sent at one fruit per day. Resistance towards H2O2-
oxidation seemed to increase somewhat more following
consumption of yellow kiwifuit than after consumption
of green kiwifruit [26], even if a direct comparison can-
not be performed between the two studies.
Supplementation with one kiwifruit per day for four
weeks protected lymphocytes against DNA base oxida-
tion, as indicated by a decrease of more than 20% in the
number of FPG-sensitive sites measured with the comet
assay. This effect was not seen after supplementation
with two kiwifruits per day. The lack of a clear dose-
response effect is not unprecedented; in our previous
study with green kiwifruit [10], protective effects against
DNA oxidation did not increase with higher daily doses
of fruits. This may represent a saturation effect, if the
active ingredient in one kiwifruit is sufficient to exert a
maximal protective effect. We presently have no idea of
the identity of the active ingredient.
Endonuclease III-sensitive sites were also reduced after
supplementation by about one quarter. The reduction
was significant after two kiwifruits per day but not after
one. There was no significant correlation between endo-
nuclease III-sensitive sites and H2O2-induced DNA
damage or plasma vitamin C, indicating that the reduc-
tion in endonuclease III-sensitive sites may be caused by
specific modulating compounds of the kiwifruits rather
than by its antioxidant content per se.
The lack of any effect of kiwifruit supplementation on
lymphocyte DNA repair - either BER or NER - is
unexpected, since a stimulation of BER was the most
pronounced effect in the previous kiwifruit study [10].
Significant effects of green kiwifruit, and of a high fruit
and vegetable diet, on both BER and NER, have been
seen in another recent intervention trial [28], and so we
can hypothesise that golden kiwifruit may lack specific
ingredient(s) that can modulate DNA repair. The lack of
significant effects of golden kiwifruit supplementation
on the expression of key DNA repair genes is consistent
with the lack of effect on repair enzyme activities. Lack
of effect of antioxidant rich whole food on repair
enzyme activities have been reported previously. Despite
reduced DNA damage and increased resistance towards
H2O2 induced strand breaks, Rizo et al. reported no
effect of broccoli consumption on the expression of
DNA repair enzymes [29].
There is increasing evidence that some natural com-
ponents can reduce levels of specific CVD risk factors
by modulating platelet function [11,30]. In recent years,
research groups including ours have reported inhibitory
effects of different fruits on platelet aggregation [11].
Potent anti-platelet-aggregation factor(s) are present in
tomatoes and green kiwifruits [11,24,25]. Extracts of
these fruits inhibit platelet aggregation in response to
ADP, collagen, and thrombin both in vitro and in vivo
[11,21,25].
In the present study, consuming 1 golden kiwifruit per
day for 4 weeks reduced whole blood platelet aggrega-
tion. This effect disappeared during the washout period
(data not shown). Consuming 2 golden kiwifruits gener-
ally did not inhibit whole blood platelet aggregation.
(Only with 7.5 μM ADP was there a marginally signifi-
cant decrease.) There is no obvious explanation for this
lack of effect, but it corresponds to the lack of dose
response in relation to markers of DNA oxidation, dis-
cussed above - though there is no reason to assume the
Table 5 Effects of daily consumption of one and two golden kiwifruits per day on whole blood aggregation (n = 24)
Aggregating agent Before After Diff Change p
Mean SEM Mean SEM Mean SEM (%)
(Resistance, Ohm) (Resistance, Ohm) (Resistance, Ohm)
One kiwifruit per day
ADP (5.0 μM) 13.00 2.7 11.40 1.95 -1.6 3.3 -12.3 0.03
ADP (7.5 μM) 13.04 2.0 11.88 2.78 -1.2 3.4 -8.9 0.08
Collagen (1 μg/ml) 16.00 2.1 15.60 2.46 -0.4 3.3 -2.5 0.53
Collagen (2 μg/ml) 18.75 2.2 16.18 1.93 -2.6 2.9 -13.7 0.00
Two kiwifruits per day
ADP (5.0 μM) 13.04 3.4 12.17 3.34 -0.9 4.7 -6.7 0.32
ADP (7.5 μM) 12.42 2.7 11.50 2.29 -0.9 3.5 -7.4 0.07
Collagen (1 μg/ml) 15.77 2.4 15.15 1.59 -0.6 2.8 -3.9 0.35
Collagen (2 μg/ml) 17.77 3.4 17.70 2.15 -0.1 4.0 -0.4 0.93
SEM: standard error of the mean.
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operation of a common molecular mechanism. The lack
of effects of 2 golden kiwifruits per day could be caused
by unknown confounders.
Our in vitro platelet aggregation experiments suggest
that green and golden kiwifruit extracts inhibit both
ADP and collagen-induced whole blood platelet aggrega-
tion (to different degrees). The fruit extract may contain
a wide variety of different types of compounds that have
anti-platelet activity in vitro and that affect different
mechanisms of activation and aggregation. We have ear-
lier shown that anti-platelet effects of fruits including
green kiwifruits and tomatoes are independent of their
antioxidant activity [11,16,25].
Consumption of golden kiwifruit reduced plasma tri-
glyceride levels without affecting cholesterol levels: origi-
nal levels were restored after the washout period (data
not shown). Lowering of plasma triglycerides by kiwifruit
was observed despite the fact that the volunteers main-
tained their regular diet during the supplementation per-
iod. Such effects of fruits and vegetables have been
reported before [31]. Our data imply that both green and
golden kiwifruits might have cardio-protective effects.
A possible limitation of the present study was the use
of healthy subjects. The protective effect of antioxidant
supplementation may be more pronounced in subjects
exposed to increased levels of oxidative stress, such as e.
g. endurance athletes, diseased or old people [31]. Mod-
erate sample size may be another limitation. Since this
was a cross-over intervention any possible weak seasonal
variation would cancel out in the final analysis, but the
inclusion of a control group could have improved our
knowledge of seasonal variations in the measured
biomarkers.
To summarise, this intervention trial, with biomarkers
relevant to both cancer and CVD indicates that one
kiwifruit per day is as effective as two per day, when
considering both effects on DNA oxidation, and platelet
aggregation. The concentration of plasma triglycerides is
decreased by golden kiwifruit, with no parallel effect on
cholesterol.
Conclusion
Regular intake of golden kiwifruit can protect against lym-
phocyte DNA oxidation as well as increase total antioxi-
dant activity and specifically plasma vitamin C. Regular
consumption can also reduce platelet aggregation, and
lower plasma triglycerides. Consumption of these fruits
could therefore benefit public health by countering oxida-
tive stress factors, and by reducing the risk of thrombotic
events mediated by platelet activation.
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